The latest closing stock price for Aclaris Therapeutics as of February 21, 2025 is 2.24.
An investor who bought $1,000 worth of Aclaris Therapeutics stock at the IPO in 2015 would have $-797 today, roughly -1 times their original investment - a -16.25% compound annual growth rate over 9 years.
The all-time high Aclaris Therapeutics stock closing price was 32.99 on April 17, 2017.
The Aclaris Therapeutics 52-week high stock price is 5.17, which is 130.8% above the current share price.
The Aclaris Therapeutics 52-week low stock price is 0.95, which is 57.6% below the current share price.
The average Aclaris Therapeutics stock price for the last 52 weeks is 1.71.
An investor who bought $1,000 worth of Aclaris Therapeutics stock at the IPO in 2015 would have $-797 today, roughly -1 times their original investment - a -16.25% compound annual growth rate over 9 years.
The all-time high Aclaris Therapeutics stock closing price was 32.99 on April 17, 2017.
The Aclaris Therapeutics 52-week high stock price is 5.17, which is 130.8% above the current share price.
The Aclaris Therapeutics 52-week low stock price is 0.95, which is 57.6% below the current share price.
The average Aclaris Therapeutics stock price for the last 52 weeks is 1.71.